Markels John 4

4 · Arcturus Therapeutics Holdings Inc. · Filed Dec 13, 2022

Insider Transaction Report

Form 4
Period: 2022-12-08
Markels John
Director
Transactions
  • Award

    Stock option (right to buy)

    2022-12-08+6,9866,986 total
    Exercise: $18.04Exp: 2032-12-08Common Stock (6,986 underlying)
  • Award

    Stock option (right to buy)

    2022-12-08+20,00020,000 total
    Exercise: $18.04Exp: 2032-12-08Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors (the "Board").
  • [F2]Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board, representing an estimated six months of service.

Documents

1 file
  • 4
    e618117_4-markels.xmlPrimary